SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
6.50
+0.17 (2.69%)
At close: Jul 21, 2026, 4:00 PM EDT
6.50
0.00 (0.00%)
Pre-market: Jul 22, 2026, 4:53 AM EDT
SOPHiA GENETICS Revenue
SOPHiA GENETICS had revenue of $21.69M in the quarter ending March 31, 2026, with 21.99% growth. This brings the company's revenue in the last twelve months to $81.18M, up 20.85% year-over-year. In the year 2025, SOPHiA GENETICS had annual revenue of $77.27M with 18.56% growth.
Revenue (ttm)
$81.18M
Revenue Growth
+20.85%
P/S Ratio
6.72
Revenue / Employee
$195,614
Employees
415
Market Cap
545.32M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.27M | 12.10M | 18.56% |
| Dec 31, 2024 | 65.17M | 2.80M | 4.49% |
| Dec 31, 2023 | 62.37M | 14.81M | 31.14% |
| Dec 31, 2022 | 47.56M | 7.11M | 17.58% |
| Dec 31, 2021 | 40.45M | 12.05M | 42.43% |
| Dec 31, 2020 | 28.40M | 3.04M | 11.98% |
| Dec 31, 2019 | 25.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 1.89B |
| Claritev | 978.76M |
| GoodRx Holdings | 787.89M |
| Phreesia | 495.59M |
| Certara | 419.75M |
| HealthStream | 311.78M |
| Weave Communications | 248.72M |
| Talkspace | 238.37M |
SOPH News
- 21 hours ago - SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 - PRNewsWire
- 1 day ago - Sophia Genetics initiated with a Buy at H.C. Wainwright - TheFly
- 4 weeks ago - SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting - PRNewsWire
- 4 weeks ago - SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - PRNewsWire
- 5 weeks ago - Sophia Genetics 10.5M share Spot Secondary priced at $4.75 - TheFly
- 5 weeks ago - SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares - PRNewsWire
- 5 weeks ago - Sophia Genetics $40M Spot Secondary re-offered at $4.75 - TheFly
- 5 weeks ago - Sophia Genetics announces ordinary share offering, no amount given - TheFly